Literature DB >> 21614403

Chiral inversion of 2-arylpropionyl-CoA esters by human α-methylacyl-CoA racemase 1A (P504S)--a potential mechanism for the anti-cancer effects of ibuprofen.

Timothy J Woodman1, Pauline J Wood, Andrew S Thompson, Thomas J Hutchings, Georgina R Steel, Ping Jiao, Michael D Threadgill, Matthew D Lloyd.   

Abstract

Metabolic chiral inversion of 2-arylpropanoic acids (2-APAs;'profens'), such as ibuprofen, is important for pharmacological activity. Several 2-APA-CoA esters were good racemisation substrates for human AMACR 1A, suggesting a common chiral inversion pathway for all 2-APAs and an additional mechanism for their anti-cancer properties.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21614403     DOI: 10.1039/c1cc10763a

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  7 in total

1.  Fifty years since the discovery of ibuprofen.

Authors:  K D Rainsford
Journal:  Inflammopharmacology       Date:  2011-12       Impact factor: 4.473

2.  AMACR overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma.

Authors:  Ying-En Lee; Hong-Lin He; Sung-Wei Lee; Tzu-Ju Chen; Kwang-Yu Chang; Chung-Hsi Hsing; Chien-Feng Li
Journal:  Tumour Biol       Date:  2014-05-16

3.  Substrate-Selective Inhibition of Cyclooxygenase-2: Development and Evaluation of Achiral Profen Probes.

Authors:  Matthew A Windsor; Daniel J Hermanson; Philip J Kingsley; Shu Xu; Brenda C Crews; Winnie Ho; Catherine M Keenan; Surajit Banerjee; Keith A Sharkey; Lawrence J Marnett
Journal:  ACS Med Chem Lett       Date:  2012-08-15       Impact factor: 4.345

4.  Stereoselectivity of Electron and Energy Transfer in the Quenching of (S/R)-Ketoprofen-(S)-Tryptophan Dyad Excited State.

Authors:  Aleksandra A Ageeva; Simon V Babenko; Ilya M Magin; Victor F Plyusnin; Polina S Kuznetsova; Alexander A Stepanov; Sergey F Vasilevsky; Nikolay E Polyakov; Alexander B Doktorov; Tatyana V Leshina
Journal:  Int J Mol Sci       Date:  2020-07-28       Impact factor: 5.923

5.  Ibuprofen nanocrystals developed by 22 factorial design experiment: A new approach for poorly water-soluble drugs.

Authors:  A R Fernandes; N R Ferreira; J F Fangueiro; A C Santos; F J Veiga; C Cabral; A M Silva; E B Souto
Journal:  Saudi Pharm J       Date:  2017-07-11       Impact factor: 4.330

Review 6.  Dexibuprofen Therapeutic Advances: Prodrugs and Nanotechnological Formulations.

Authors:  Anna Gliszczyńska; Elena Sánchez-López
Journal:  Pharmaceutics       Date:  2021-03-19       Impact factor: 6.321

Review 7.  Chiral Linked Systems as a Model for Understanding D-Amino Acids Influence on the Structure and Properties of Amyloid Peptides.

Authors:  Aleksandra A Ageeva; Alexander B Doktorov; Nikolay E Polyakov; Tatyana V Leshina
Journal:  Int J Mol Sci       Date:  2022-03-11       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.